{"id":2120,"date":"2026-07-21T11:27:34","date_gmt":"2026-07-21T09:27:34","guid":{"rendered":"https:\/\/filiere-ia.fr\/2025-sector-day\/jdlfia-2025-panel-3\/"},"modified":"2026-07-22T16:03:41","modified_gmt":"2026-07-22T14:03:41","slug":"jdlfia-2025-panel-3","status":"publish","type":"page","link":"https:\/\/filiere-ia.fr\/en\/2025-sector-day\/jdlfia-2025-panel-3\/","title":{"rendered":"JDLFIA 2025 – Panel 3"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
JFIAC 2025: Panel 3<\/div>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

The SNDS:<\/b> Expanding the SNDS to Understand Care Pathways: Limitations and Potential<\/h1>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tDiscover the speakers' profiles<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tThis panel, moderated by Yann-Ma\u00ebl Le Douarin (DGOS), will explore the uses, strengths, and limitations of the SNDS, one of the largest medico-administrative data repositories in the world. Why and how should we leverage this vast database to improve our knowledge, transform research, and guide our health policies more effectively?\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

Moderator<\/h2>\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tYann-Ma\u00ebl LE DOUARIN<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tHead of the Health and Digital Transformation Department at the Directorate General for Healthcare Supply<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Holding a specialized degree (DES) in general medicine and a specialized master’s degree from ESSEC in strategy and management of health industries, Yann Ma\u00ebl Le Douarin began his career in 2013 as a general practitioner in Paris.<\/p>\n

After a period in the pharmaceutical industry, he joined the Ministry of Solidarity and Health in 2017 as a telehealth medical advisor, then was appointed deputy at the DGOS in charge of cooperation and contracting.<\/p>\n

In April 2024, he was appointed head of the new Health and Digital Transformation Department (DSTN) as part of the directorate’s reorganization. This department is responsible for steering and coordinating the DGOS’s action in supporting new practices and their regulation.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Speakers<\/h2>\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tNathalie Varoqueaux<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tHead of the \"Data and Health Evaluation\" Department at the National Cancer InstituteMedical Director at Amgen France<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr. Nathalie Varoqueaux, MD, PhD, is the Medical Director of Amgen France.<\/p>\n

A specialist in hematology, she holds a PhD in Science from Paris VI Pierre and Marie Curie University in cellular and molecular biology. She has held various senior positions in several pharmaceutical companies, such as Roche, Alexion, and AstraZeneca, in medical affairs, business development, and pharmacovigilance.<\/p>\n

N. Varoqueaux is also Vice President of ARIIS, Vice President of the LEEM Research and Innovation Commission, and a board member of the AI & Cancer Sector.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tChristine LE BIHAN<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tHead of the \"Data and Health Evaluation\" Department at the National Cancer Institute<\/span>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tAlexandre VAINCHTOCK<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tDeputy Chief Executive Officer of HEVA<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Alexandre is a pharmacist and health economist. He began his career in 1998 at a consulting firm specializing in health economics, then co-founded HEVA in 2005, a pioneer in the analysis and processing of health data, particularly medico-administrative databases.<\/p>\n

HEVA joined the Docaposte group in April 2022, is now the data business unit of the La Poste Sant\u00e9 & Autonomie brand, and comprises nearly 100 employees who are experts in the collection, analysis, and processing of health data, both primary and secondary.<\/p>\n

He serves as Deputy Chief Executive Officer, responsible in particular for development and public relations.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tFran\u00e7ois MARGRAFF<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tRWD & PHC Lead at Roche Pharma<\/span>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tJ\u00e9r\u00f4me KRULIK<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tHead of Oncology Medical Affairs at Pfizer France<\/span>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

JFIAC 2025: Panel 3 The SNDS: Expanding the SNDS to Understand Care Pathways: Limitations and Potential Discover the speakers’ profiles This panel, moderated by Yann-Ma\u00ebl Le Douarin (DGOS), will explore the uses, strengths, and limitations of the SNDS, one of the largest medico-administrative data repositories in the world. Why and how should we leverage this […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2111,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-2120","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages\/2120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/comments?post=2120"}],"version-history":[{"count":2,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages\/2120\/revisions"}],"predecessor-version":[{"id":2264,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages\/2120\/revisions\/2264"}],"up":[{"embeddable":true,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages\/2111"}],"wp:attachment":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/media?parent=2120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}